These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 26072703)

  • 1. Improvement and prevention of asthma with concomitant treatment of allergic rhinitis and allergen-specific therapy.
    Mener DJ; Lin SY
    Int Forum Allergy Rhinol; 2015 Sep; 5 Suppl 1():S45-50. PubMed ID: 26072703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical practice guideline: Allergic rhinitis.
    Seidman MD; Gurgel RK; Lin SY; Schwartz SR; Baroody FM; Bonner JR; Dawson DE; Dykewicz MS; Hackell JM; Han JK; Ishman SL; Krouse HJ; Malekzadeh S; Mims JW; Omole FS; Reddy WD; Wallace DV; Walsh SA; Warren BE; Wilson MN; Nnacheta LC;
    Otolaryngol Head Neck Surg; 2015 Feb; 152(1 Suppl):S1-43. PubMed ID: 25644617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of standardised specific subcutaneous immunotherapy in children with persistent allergic rhinitis due to multiple allergens including house dust mites.
    Song Y; Long J; Wang T; Xie J; Wang M; Tan G
    J Laryngol Otol; 2018 Mar; 132(3):230-235. PubMed ID: 29374499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma.
    Brunton S; Nelson HS; Bernstein DI; Lawton S; Lu S; Nolte H
    Postgrad Med; 2017 Aug; 129(6):581-589. PubMed ID: 28326908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
    Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB
    J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis.
    Đurić-Filipović I; Caminati M; Kostić G; Filipović Đ; Živković Z
    World J Pediatr; 2016 Aug; 12(3):283-290. PubMed ID: 27351563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Subcutaneous and Sublingual Immunotherapy for Allergic Rhinoconjunctivitis and Asthma.
    Roxbury CR; Lin SY
    Otolaryngol Clin North Am; 2017 Dec; 50(6):1111-1119. PubMed ID: 28964530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cost-Effectiveness of Allergen Immunotherapy Compared with Pharmacotherapy for Treatment of Allergic Rhinitis and Asthma.
    Cox LS; Murphey A; Hankin C
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):69-85. PubMed ID: 31761122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Allergic rhinitis in children].
    Richter D
    Acta Med Croatica; 2011; 65(2):163-8. PubMed ID: 22359883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic Rhinitis.
    Cohen B
    Pediatr Rev; 2023 Oct; 44(10):537-550. PubMed ID: 37777655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The impact of subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus on the quality of life of patients with allergic rhinitis and asthma].
    Yepes-Núñez JJ; Gómez C; Espinoza Y; Cardona R
    Biomedica; 2014; 34(2):282-90. PubMed ID: 24967933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in upper airway diseases and allergen immunotherapy.
    Nelson HS
    J Allergy Clin Immunol; 2007 Apr; 119(4):872-80. PubMed ID: 17292953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current issues on sublingual allergen-specific immunotherapy in children with asthma and allergic rhinitis.
    Živković Z; Djurić-Filipović I; Živanović S
    Srp Arh Celok Lek; 2016; 144(5-6):345-50. PubMed ID: 29648760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Allergic Rhinitis: A Review for the Community Pharmacist.
    May JR; Dolen WK
    Clin Ther; 2017 Dec; 39(12):2410-2419. PubMed ID: 29079387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
    Polzehl D; Keck T; Riechelmann H
    Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of regulatory T cells by intranasal allergen immunotherapy in an experimental rat model of airway allergy.
    Moitra S; Datta A; Mondal S; Hazra I; Faruk SMO; Das PK; Basu AK; Tripathi SK; Chaudhuri S
    Int Immunopharmacol; 2017 Jun; 47():9-19. PubMed ID: 28349869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergic rhinitis.
    Kemp AS
    Paediatr Respir Rev; 2009 Jun; 10(2):63-8. PubMed ID: 19410204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updates in the diagnosis and practical management of allergic rhinitis.
    Trincianti C; Tosca MA; Ciprandi G
    Expert Rev Clin Pharmacol; 2023; 16(7):669-676. PubMed ID: 37314373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responders and nonresponders to pharmacotherapy and allergen immunotherapy.
    Jakalski M; Bozek A; Canonica GW
    Hum Vaccin Immunother; 2019; 15(12):2896-2902. PubMed ID: 31070995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.